Actively Recruiting
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Led by The University of Texas Health Science Center, Houston · Updated on 2026-05-04
225
Participants Needed
1
Research Sites
176 weeks
Total Duration
On this page
Sponsors
T
The University of Texas Health Science Center, Houston
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites
CONDITIONS
Official Title
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Federally Qualified Health Centers (FQHCs) with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents
- FQHCs that have family medicine and/or pediatric practices
- Total adolescent patient population at least 50% Latino
- Willingness for healthcare providers and staff to receive education, training, support, complete measurements, and agree to randomization
- Providers aged 18 and over employed at each FQHC (4 staff per practice)
- Staff aged 18 and over employed at each FQHC (5 staff per practice)
- Implementation team members aged 18 and over employed at each FQHC (4 members per practice)
- Parents aged 18 and over of patients aged 11-17 seeking care at each FQHC (25 per practice)
You will not qualify if you...
- FQHCs that participated in the pilot study were excluded
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
D
Daisy Y Morales-Campos, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here